Primary Progressive MS: Does Gender Matter?
…
Roche’s new multiple sclerosis drug set for early FDA approval
…
Stuart Schlossman
A New Model of MS – “The Topographical Model of MS”
…
Stuart Schlossman
Resources and support for Veterans, children with pediatric MS, and African American and Hispanic/Latino individuals living with and affected by MS
…
Stuart Schlossman
Primary Progressive MS: Does Gender Matter?
…
Stuart Schlossman
Promising Phase 1 Trial Results of Stem Cell Therapy in Progressive MS Patients Being Presented at AAN Meeting
…
Stuart Schlossman
Biotin (Cerenday) for primary and secondary progressive multiple sclerosis – first line NIHR HSRIC
Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this…
Stuart Schlossman
MS SMART -Multiple Sclerosis – Secondary Progressive Multi-Arm Randomisation Trial
Update 1st April 2015 MS-SMART has started and recruitment into the trial will continue through 2015. Two centres are currently…
Stuart Schlossman
B Vitamin Promising in Progressive Multiple Sclerosis
Pauline Anderson Washington, DC — A regimen of high doses of biotin, a water-soluble B vitamin, appears to be effective…
Stuart Schlossman
NEWS FLASH for people with PPMS— FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S INVESTIGATIONAL MEDICINE OCRELIZUMAB IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
· Ocrelizumab is the first investigational medicine to receive Breakthrough Therapy Designation in multiple sclerosis (MS) · Twelfth Breakthrough Therapy…
Stuart Schlossman
